共 31 条
- [1] Hansen’s Disease (Leprosy), (2017)
- [2] Makhakhe L., South African Family Practice, (2021)
- [3] Saunderson P., WHO Global leprosy (Hansen’s disease) update, 2022: New paradigm–control to elimination, 94, pp. 262-263, (2023)
- [4] Lockwood D., Leprosy BMJ Clin Evid, (2007)
- [5] Lockwood DNJL Warwick J., THE LANCET, (2004)
- [6] Mohammad AS, Mia T, Hamid M, Hossain S, Khan ZH., Association of Testosterone Level among Lepromatous and Borderline Leprosy Male Patients: Experience of 30 Cases in Bangladesh, Bangladesh Journal of Infectious Diseases, 7, 2, pp. 36-39, (2021)
- [7] Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Et al., Testosterone therapy in men with androgen deficiency syndromes: An endocrine society clinical practice guideline, Journal of Clinical Endocrinology and Metabolism, 95, pp. 2536-2559, (2010)
- [8] Guler H, Kadihasanoglu M, Aydin M, Kendirci M., Erectile dysfunction and adult onset hypogonadism in leprosy: cross-sectional, control group study, Lepr Rev, (2019)
- [9] Thirumalai A, Anawalt BD., Epidemiology of Male Hypogonadism, Endocrinology and Metabolism Clinics of North America, 51, pp. 1-27, (2022)
- [10] Yeo S, Holl K, Penaherrera N, Wissinger U, Anstee K, Wyn R., Burden of male hypogonadism and major comorbidities, and the clinical, economic, and humanistic benefits of testosterone therapy: A narrative review, 13, pp. 31-38, (2021)